Nucleoside reverse transcriptase inhibitors (NRTIs)

GX CG5 Pill - brown capsule-shape

Pill with imprint GX CG5 is Brown, Capsule-shape and has been identified as Lamivudine 100 mg. It is supplied by Prasco Laboratories.

Lamivudine is used in the treatment of Hepatitis B; HIV Infection; Occupational Exposure; Nonoccupational Exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Lamivudine (Lamivudine [ la-miv-ue-deen ])-GX CG5-100 mg-Brown-Capsule-shape
Lamivudine (Lamivudine [ la-miv-ue-deen ])-GX CG5-100 mg-Brown-Capsule-shape
Lamivudine (Lamivudine [ la-miv-ue-deen ])-GX CG5-100 mg-Brown-Capsule-shape

Lamivudine
Generic Name: lamivudine [ la-miv-ue-deen ]
Imprint: GX CG5
Strength: 100 mg
Color: Brown
Size: N/A
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): N/A
Inactive Ingredients: Hypromelloses, Polyethylene glycol, Magnesium stearate, Microcrystalline cellulose, Polysorbate 80, Ferric oxide red, Sodium starch glycolate type A potato, Titanium dioxide, Ferric oxide yellow,
Latest News
Related Drugs